2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 0 | 0 | 450 | 4.839 | 4.352 | 2.995 | 774 | 0 | 0 | 6.997 |
Total Income - EUR | 0 | 1 | 450 | 4.839 | 4.352 | 2.995 | 774 | 0 | 0 | 6.997 |
Total Expenses - EUR | 1.330 | 3.447 | 10.146 | 9.825 | 7.654 | 3.300 | 4.063 | 168 | 51 | 3.236 |
Gross Profit/Loss - EUR | -1.329 | -3.446 | -9.695 | -4.986 | -3.302 | -306 | -3.289 | -168 | -51 | 3.761 |
Net Profit/Loss - EUR | -1.329 | -3.446 | -9.710 | -5.126 | -3.374 | -386 | -3.313 | -168 | -51 | 3.557 |
Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Erroso Bio International S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 87 | 5.764 | 5.579 | 4.744 | 3.659 | 979 | 0 | 0 | 0 | 0 |
Current Assets | 344 | 5.141 | 5.047 | 12.781 | 9.875 | 2.263 | 122 | 0 | 10 | 4.027 |
Inventories | 31 | 1.075 | 2.419 | 11.298 | 8.519 | 1.828 | 0 | 0 | 0 | 0 |
Receivables | 166 | 3.527 | 2.583 | 1.355 | 1.221 | 333 | 122 | 0 | 0 | 3.228 |
Cash | 147 | 538 | 45 | 128 | 135 | 102 | 0 | 0 | 10 | 799 |
Shareholders Funds | -2.167 | -5.631 | -15.284 | -20.152 | -22.158 | -28.333 | -31.109 | -30.587 | -30.732 | -27.203 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 2.597 | 16.536 | 25.911 | 37.677 | 35.692 | 31.575 | 31.231 | 30.587 | 30.743 | 31.231 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "7111 - 7111" | |||||||||
CAEN Financial Year |
4619
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Erroso Bio International S.r.l.